aluates Reports

$ 0.0

Automative

Global DA2PP (DHPP) Vaccine Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-2P18748

BUY CHAPTERS

Global DA2PP (DHPP) Vaccine Market Research Report 2024

Code: QYRE-Auto-2P18748

Report

November 2024

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Elanco

Boehringer Ingelheim

Pfizer Inc

Zoetis Inc

Merck Animal Health

Virbac

Durvet

RuiPu Bio-Technology

CAHIC

Wuhan Keqian Biology

Neotech

Jilin Five-Star Animal Health

DA2PP (DHPP) Vaccine Market Size

The global DA2PP (DHPP) Vaccine market was valued at US$ 822 million in 2023 and is anticipated to reach US$ 1215 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.

DA2PP (DHPP) Vaccine Market

The DA2PP vaccine, also known as the DHPP vaccine, is a core vaccine for dogs that protects against four highly contagious and potentially fatal diseases: D - Distemper; A2 - Adenovirus Type 2 (also called Hepatitis); P - Parainfluenza; P - Parvovirus.

North American market for DA2PP (DHPP) Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for DA2PP (DHPP) Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of DA2PP (DHPP) Vaccine include Zoetis, Merck Animal Health, Pfizer, Boehringer Ingelheim, Virbac, Durvet, Elanco, RuiPu Bio-Technology, CAHIC, Wuhan Keqian Biology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DA2PP (DHPP) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DA2PP (DHPP) Vaccine.

The DA2PP (DHPP) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global DA2PP (DHPP) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the DA2PP (DHPP) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of DA2PP (DHPP) Vaccine Market Report

Report Metric	Details
Report Name	DA2PP (DHPP) Vaccine Market
Accounted market size in 2023	US$ 822 million
Forecasted market size in 2030	US$ 1215 million
CAGR	5.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Inactivated Vaccines Live Attenuated Vaccines
Segment by Application	Puppies Adult Dogs
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Zoetis, Merck Animal Health, Pfizer, Boehringer Ingelheim, Virbac, Durvet, Elanco, RuiPu Bio-Technology, CAHIC, Wuhan Keqian Biology, Jilin Five-Star Animal Health, NeoTech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DA2PP (DHPP) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DA2PP (DHPP) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is DA2PP (DHPP) Vaccine Market growing?

Ans: The DA2PP (DHPP) Vaccine Market witnessing a CAGR of 5.7% during the forecast period 2024-2030.

What is the DA2PP (DHPP) Vaccine Market size in 2030?

Ans: The DA2PP (DHPP) Vaccine Market size in 2030 will be US$ 1215 million.

Who are the main players in the DA2PP (DHPP) Vaccine Market report?

Ans: The main players in the DA2PP (DHPP) Vaccine Market are Zoetis, Merck Animal Health, Pfizer, Boehringer Ingelheim, Virbac, Durvet, Elanco, RuiPu Bio-Technology, CAHIC, Wuhan Keqian Biology, Jilin Five-Star Animal Health, NeoTech

What are the Application segmentation covered in the DA2PP (DHPP) Vaccine Market report?

Ans: The Applications covered in the DA2PP (DHPP) Vaccine Market report are Puppies, Adult Dogs

What are the Type segmentation covered in the DA2PP (DHPP) Vaccine Market report?

Ans: The Types covered in the DA2PP (DHPP) Vaccine Market report are Inactivated Vaccines, Live Attenuated Vaccines

Recommended Reports

Veterinary Vaccines

Combination Vaccines

Flu & Specialty Vaccines

1 DA2PP (DHPP) Vaccine Market Overview

1.1 Product Definition

1.2 DA2PP (DHPP) Vaccine by Type

1.2.1 Global DA2PP (DHPP) Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Inactivated Vaccines

1.2.3 Live Attenuated Vaccines

1.3 DA2PP (DHPP) Vaccine by Application

1.3.1 Global DA2PP (DHPP) Vaccine Market Value by Application (2024-2030)

1.3.2 Puppies

1.3.3 Adult Dogs

1.4 Global DA2PP (DHPP) Vaccine Market Size Estimates and Forecasts

1.4.1 Global DA2PP (DHPP) Vaccine Revenue 2019-2030

1.4.2 Global DA2PP (DHPP) Vaccine Sales 2019-2030

1.4.3 Global DA2PP (DHPP) Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 DA2PP (DHPP) Vaccine Market Competition by Manufacturers

2.1 Global DA2PP (DHPP) Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global DA2PP (DHPP) Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global DA2PP (DHPP) Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of DA2PP (DHPP) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of DA2PP (DHPP) Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of DA2PP (DHPP) Vaccine, Product Type & Application

2.7 Global Key Manufacturers of DA2PP (DHPP) Vaccine, Date of Enter into This Industry

2.8 Global DA2PP (DHPP) Vaccine Market Competitive Situation and Trends

2.8.1 Global DA2PP (DHPP) Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest DA2PP (DHPP) Vaccine Players Market Share by Revenue

2.8.3 Global DA2PP (DHPP) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global DA2PP (DHPP) Vaccine Market Scenario by Region

3.1 Global DA2PP (DHPP) Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global DA2PP (DHPP) Vaccine Sales by Region: 2019-2030

3.2.1 Global DA2PP (DHPP) Vaccine Sales by Region: 2019-2024

3.2.2 Global DA2PP (DHPP) Vaccine Sales by Region: 2025-2030

3.3 Global DA2PP (DHPP) Vaccine Revenue by Region: 2019-2030

3.3.1 Global DA2PP (DHPP) Vaccine Revenue by Region: 2019-2024

3.3.2 Global DA2PP (DHPP) Vaccine Revenue by Region: 2025-2030

3.4 North America DA2PP (DHPP) Vaccine Market Facts & Figures by Country

3.4.1 North America DA2PP (DHPP) Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America DA2PP (DHPP) Vaccine Sales by Country (2019-2030)

3.4.3 North America DA2PP (DHPP) Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe DA2PP (DHPP) Vaccine Market Facts & Figures by Country

3.5.1 Europe DA2PP (DHPP) Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe DA2PP (DHPP) Vaccine Sales by Country (2019-2030)

3.5.3 Europe DA2PP (DHPP) Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific DA2PP (DHPP) Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific DA2PP (DHPP) Vaccine Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific DA2PP (DHPP) Vaccine Sales by Region (2019-2030)

3.6.3 Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America DA2PP (DHPP) Vaccine Market Facts & Figures by Country

3.7.1 Latin America DA2PP (DHPP) Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America DA2PP (DHPP) Vaccine Sales by Country (2019-2030)

3.7.3 Latin America DA2PP (DHPP) Vaccine Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa DA2PP (DHPP) Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa DA2PP (DHPP) Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa DA2PP (DHPP) Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global DA2PP (DHPP) Vaccine Sales by Type (2019-2030)

4.1.1 Global DA2PP (DHPP) Vaccine Sales by Type (2019-2024)

4.1.2 Global DA2PP (DHPP) Vaccine Sales by Type (2025-2030)

4.1.3 Global DA2PP (DHPP) Vaccine Sales Market Share by Type (2019-2030)

4.2 Global DA2PP (DHPP) Vaccine Revenue by Type (2019-2030)

4.2.1 Global DA2PP (DHPP) Vaccine Revenue by Type (2019-2024)

4.2.2 Global DA2PP (DHPP) Vaccine Revenue by Type (2025-2030)

4.2.3 Global DA2PP (DHPP) Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global DA2PP (DHPP) Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global DA2PP (DHPP) Vaccine Sales by Application (2019-2030)

5.1.1 Global DA2PP (DHPP) Vaccine Sales by Application (2019-2024)

5.1.2 Global DA2PP (DHPP) Vaccine Sales by Application (2025-2030)

5.1.3 Global DA2PP (DHPP) Vaccine Sales Market Share by Application (2019-2030)

5.2 Global DA2PP (DHPP) Vaccine Revenue by Application (2019-2030)

5.2.1 Global DA2PP (DHPP) Vaccine Revenue by Application (2019-2024)

5.2.2 Global DA2PP (DHPP) Vaccine Revenue by Application (2025-2030)

5.2.3 Global DA2PP (DHPP) Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global DA2PP (DHPP) Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Zoetis

6.1.1 Zoetis Company Information

6.1.2 Zoetis Description and Business Overview

6.1.3 Zoetis DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Zoetis DA2PP (DHPP) Vaccine Product Portfolio

6.1.5 Zoetis Recent Developments/Updates

6.2 Merck Animal Health

6.2.1 Merck Animal Health Company Information

6.2.2 Merck Animal Health Description and Business Overview

6.2.3 Merck Animal Health DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Merck Animal Health DA2PP (DHPP) Vaccine Product Portfolio

6.2.5 Merck Animal Health Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Company Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Pfizer DA2PP (DHPP) Vaccine Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Boehringer Ingelheim

6.4.1 Boehringer Ingelheim Company Information

6.4.2 Boehringer Ingelheim Description and Business Overview

6.4.3 Boehringer Ingelheim DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Boehringer Ingelheim DA2PP (DHPP) Vaccine Product Portfolio

6.4.5 Boehringer Ingelheim Recent Developments/Updates

6.5 Virbac

6.5.1 Virbac Company Information

6.5.2 Virbac Description and Business Overview

6.5.3 Virbac DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Virbac DA2PP (DHPP) Vaccine Product Portfolio

6.5.5 Virbac Recent Developments/Updates

6.6 Durvet

6.6.1 Durvet Company Information

6.6.2 Durvet Description and Business Overview

6.6.3 Durvet DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Durvet DA2PP (DHPP) Vaccine Product Portfolio

6.6.5 Durvet Recent Developments/Updates

6.7 Elanco

6.7.1 Elanco Company Information

6.7.2 Elanco Description and Business Overview

6.7.3 Elanco DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Elanco DA2PP (DHPP) Vaccine Product Portfolio

6.7.5 Elanco Recent Developments/Updates

6.8 RuiPu Bio-Technology

6.8.1 RuiPu Bio-Technology Company Information

6.8.2 RuiPu Bio-Technology Description and Business Overview

6.8.3 RuiPu Bio-Technology DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 RuiPu Bio-Technology DA2PP (DHPP) Vaccine Product Portfolio

6.8.5 RuiPu Bio-Technology Recent Developments/Updates

6.9 CAHIC

6.9.1 CAHIC Company Information

6.9.2 CAHIC Description and Business Overview

6.9.3 CAHIC DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.9.4 CAHIC DA2PP (DHPP) Vaccine Product Portfolio

6.9.5 CAHIC Recent Developments/Updates

6.10 Wuhan Keqian Biology

6.10.1 Wuhan Keqian Biology Company Information

6.10.2 Wuhan Keqian Biology Description and Business Overview

6.10.3 Wuhan Keqian Biology DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Wuhan Keqian Biology DA2PP (DHPP) Vaccine Product Portfolio

6.10.5 Wuhan Keqian Biology Recent Developments/Updates

6.11 Jilin Five-Star Animal Health

6.11.1 Jilin Five-Star Animal Health Company Information

6.11.2 Jilin Five-Star Animal Health Description and Business Overview

6.11.3 Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Product Portfolio

6.11.5 Jilin Five-Star Animal Health Recent Developments/Updates

6.12 NeoTech

6.12.1 NeoTech Company Information

6.12.2 NeoTech Description and Business Overview

6.12.3 NeoTech DA2PP (DHPP) Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.12.4 NeoTech DA2PP (DHPP) Vaccine Product Portfolio

6.12.5 NeoTech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 DA2PP (DHPP) Vaccine Industry Chain Analysis

7.2 DA2PP (DHPP) Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 DA2PP (DHPP) Vaccine Production Mode & Process

7.4 DA2PP (DHPP) Vaccine Sales and Marketing

7.4.1 DA2PP (DHPP) Vaccine Sales Channels

7.4.2 DA2PP (DHPP) Vaccine Distributors

7.5 DA2PP (DHPP) Vaccine Customers

8 DA2PP (DHPP) Vaccine Market Dynamics

8.1 DA2PP (DHPP) Vaccine Industry Trends

8.2 DA2PP (DHPP) Vaccine Market Drivers

8.3 DA2PP (DHPP) Vaccine Market Challenges

8.4 DA2PP (DHPP) Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Elanco

Boehringer Ingelheim

Pfizer Inc

Zoetis Inc

Merck Animal Health

Virbac

Durvet

RuiPu Bio-Technology

CAHIC

Wuhan Keqian Biology

Neotech

Jilin Five-Star Animal Health

List of Tables

Table 1. Global DA2PP (DHPP) Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global DA2PP (DHPP) Vaccine Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global DA2PP (DHPP) Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global DA2PP (DHPP) Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global DA2PP (DHPP) Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global DA2PP (DHPP) Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market DA2PP (DHPP) Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of DA2PP (DHPP) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of DA2PP (DHPP) Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of DA2PP (DHPP) Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of DA2PP (DHPP) Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global DA2PP (DHPP) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DA2PP (DHPP) Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global DA2PP (DHPP) Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global DA2PP (DHPP) Vaccine Sales by Region (2019-2024) & (K Units)

Table 18. Global DA2PP (DHPP) Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global DA2PP (DHPP) Vaccine Sales by Region (2025-2030) & (K Units)

Table 20. Global DA2PP (DHPP) Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global DA2PP (DHPP) Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global DA2PP (DHPP) Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global DA2PP (DHPP) Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global DA2PP (DHPP) Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America DA2PP (DHPP) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America DA2PP (DHPP) Vaccine Sales by Country (2019-2024) & (K Units)

Table 27. North America DA2PP (DHPP) Vaccine Sales by Country (2025-2030) & (K Units)

Table 28. North America DA2PP (DHPP) Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America DA2PP (DHPP) Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe DA2PP (DHPP) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe DA2PP (DHPP) Vaccine Sales by Country (2019-2024) & (K Units)

Table 32. Europe DA2PP (DHPP) Vaccine Sales by Country (2025-2030) & (K Units)

Table 33. Europe DA2PP (DHPP) Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe DA2PP (DHPP) Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific DA2PP (DHPP) Vaccine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific DA2PP (DHPP) Vaccine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific DA2PP (DHPP) Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America DA2PP (DHPP) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America DA2PP (DHPP) Vaccine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America DA2PP (DHPP) Vaccine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America DA2PP (DHPP) Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America DA2PP (DHPP) Vaccine Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa DA2PP (DHPP) Vaccine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa DA2PP (DHPP) Vaccine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa DA2PP (DHPP) Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global DA2PP (DHPP) Vaccine Sales (K Units) by Type (2019-2024)

Table 51. Global DA2PP (DHPP) Vaccine Sales (K Units) by Type (2025-2030)

Table 52. Global DA2PP (DHPP) Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global DA2PP (DHPP) Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global DA2PP (DHPP) Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global DA2PP (DHPP) Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Type (2019-2024)

Table 59. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Type (2025-2030)

Table 60. Global DA2PP (DHPP) Vaccine Sales (K Units) by Application (2019-2024)

Table 61. Global DA2PP (DHPP) Vaccine Sales (K Units) by Application (2025-2030)

Table 62. Global DA2PP (DHPP) Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global DA2PP (DHPP) Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global DA2PP (DHPP) Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global DA2PP (DHPP) Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global DA2PP (DHPP) Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Application (2019-2024)

Table 69. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Application (2025-2030)

Table 70. Zoetis Company Information

Table 71. Zoetis Description and Business Overview

Table 72. Zoetis DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Zoetis DA2PP (DHPP) Vaccine Product

Table 74. Zoetis Recent Developments/Updates

Table 75. Merck Animal Health Company Information

Table 76. Merck Animal Health Description and Business Overview

Table 77. Merck Animal Health DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Merck Animal Health DA2PP (DHPP) Vaccine Product

Table 79. Merck Animal Health Recent Developments/Updates

Table 80. Pfizer Company Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Pfizer DA2PP (DHPP) Vaccine Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Boehringer Ingelheim Company Information

Table 86. Boehringer Ingelheim Description and Business Overview

Table 87. Boehringer Ingelheim DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Boehringer Ingelheim DA2PP (DHPP) Vaccine Product

Table 89. Boehringer Ingelheim Recent Developments/Updates

Table 90. Virbac Company Information

Table 91. Virbac Description and Business Overview

Table 92. Virbac DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Virbac DA2PP (DHPP) Vaccine Product

Table 94. Virbac Recent Developments/Updates

Table 95. Durvet Company Information

Table 96. Durvet Description and Business Overview

Table 97. Durvet DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Durvet DA2PP (DHPP) Vaccine Product

Table 99. Durvet Recent Developments/Updates

Table 100. Elanco Company Information

Table 101. Elanco Description and Business Overview

Table 102. Elanco DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Elanco DA2PP (DHPP) Vaccine Product

Table 104. Elanco Recent Developments/Updates

Table 105. RuiPu Bio-Technology Company Information

Table 106. RuiPu Bio-Technology Description and Business Overview

Table 107. RuiPu Bio-Technology DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. RuiPu Bio-Technology DA2PP (DHPP) Vaccine Product

Table 109. RuiPu Bio-Technology Recent Developments/Updates

Table 110. CAHIC Company Information

Table 111. CAHIC Description and Business Overview

Table 112. CAHIC DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. CAHIC DA2PP (DHPP) Vaccine Product

Table 114. CAHIC Recent Developments/Updates

Table 115. Wuhan Keqian Biology Company Information

Table 116. Wuhan Keqian Biology Description and Business Overview

Table 117. Wuhan Keqian Biology DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Wuhan Keqian Biology DA2PP (DHPP) Vaccine Product

Table 119. Wuhan Keqian Biology Recent Developments/Updates

Table 120. Jilin Five-Star Animal Health Company Information

Table 121. Jilin Five-Star Animal Health Description and Business Overview

Table 122. Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Jilin Five-Star Animal Health DA2PP (DHPP) Vaccine Product

Table 124. Jilin Five-Star Animal Health Recent Developments/Updates

Table 125. NeoTech Company Information

Table 126. NeoTech Description and Business Overview

Table 127. NeoTech DA2PP (DHPP) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. NeoTech DA2PP (DHPP) Vaccine Product

Table 129. NeoTech Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. DA2PP (DHPP) Vaccine Distributors List

Table 133. DA2PP (DHPP) Vaccine Customers List

Table 134. DA2PP (DHPP) Vaccine Market Trends

Table 135. DA2PP (DHPP) Vaccine Market Drivers

Table 136. DA2PP (DHPP) Vaccine Market Challenges

Table 137. DA2PP (DHPP) Vaccine Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of DA2PP (DHPP) Vaccine

Figure 2. Global DA2PP (DHPP) Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global DA2PP (DHPP) Vaccine Market Share by Type: 2023 & 2030

Figure 4. Inactivated Vaccines Product Picture

Figure 5. Live Attenuated Vaccines Product Picture

Figure 6. Global DA2PP (DHPP) Vaccine Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global DA2PP (DHPP) Vaccine Market Share by Application: 2023 & 2030

Figure 8. Puppies

Figure 9. Adult Dogs

Figure 10. Global DA2PP (DHPP) Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global DA2PP (DHPP) Vaccine Market Size (2019-2030) & (US$ Million)

Figure 12. Global DA2PP (DHPP) Vaccine Sales (2019-2030) & (K Units)

Figure 13. Global DA2PP (DHPP) Vaccine Average Price (US$/Unit) & (2019-2030)

Figure 14. DA2PP (DHPP) Vaccine Report Years Considered

Figure 15. DA2PP (DHPP) Vaccine Sales Share by Manufacturers in 2023

Figure 16. Global DA2PP (DHPP) Vaccine Revenue Share by Manufacturers in 2023

Figure 17. Global 5 and 10 Largest DA2PP (DHPP) Vaccine Players: Market Share by Revenue in DA2PP (DHPP) Vaccine in 2023

Figure 18. DA2PP (DHPP) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 19. Global DA2PP (DHPP) Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America DA2PP (DHPP) Vaccine Sales Market Share by Country (2019-2030)

Figure 21. North America DA2PP (DHPP) Vaccine Revenue Market Share by Country (2019-2030)

Figure 22. United States DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe DA2PP (DHPP) Vaccine Sales Market Share by Country (2019-2030)

Figure 25. Europe DA2PP (DHPP) Vaccine Revenue Market Share by Country (2019-2030)

Figure 26. Germany DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific DA2PP (DHPP) Vaccine Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific DA2PP (DHPP) Vaccine Revenue Market Share by Region (2019-2030)

Figure 33. China DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America DA2PP (DHPP) Vaccine Sales Market Share by Country (2019-2030)

Figure 41. Mexico DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Brazil DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Argentina DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Colombia DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Middle East and Africa DA2PP (DHPP) Vaccine Sales Market Share by Country (2019-2030)

Figure 46. Middle East and Africa DA2PP (DHPP) Vaccine Revenue Market Share by Country (2019-2030)

Figure 47. Turkey DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. UAE DA2PP (DHPP) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Global Sales Market Share of DA2PP (DHPP) Vaccine by Type (2019-2030)

Figure 51. Global Revenue Market Share of DA2PP (DHPP) Vaccine by Type (2019-2030)

Figure 52. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Type (2019-2030)

Figure 53. Global Sales Market Share of DA2PP (DHPP) Vaccine by Application (2019-2030)

Figure 54. Global Revenue Market Share of DA2PP (DHPP) Vaccine by Application (2019-2030)

Figure 55. Global DA2PP (DHPP) Vaccine Price (US$/Unit) by Application (2019-2030)

Figure 56. DA2PP (DHPP) Vaccine Value Chain

Figure 57. DA2PP (DHPP) Vaccine Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pet Vaccine Market Research Report 2025

Global Canine Influenza Vaccine Market Research Report 2024

Global DPT Vaccines Market Research Report 2025

Global DPT Vaccination Market Research Report 2025

Global Dog Vaccines Market Insights Forecast to 2030

Canine Flu Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cat and Dog Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccinations Solutions for Pets Market Research Report 2025

Global Rabies Vaccine for Pets Market Research Report 2024

Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025

Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Research Report 2024

Veterinary Vaccine Market

Global Canine Distemper Virus Antigen Colloidal Gold Rapid Test Card Market Research Report 2024

Global Leptospirosis Vaccine Market Research Report 2024

Aquatic Animal Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary DNA Vaccines Market Research Report 2024

Global Canine Distemper Virus Antigen Test Strips Market Research Report 2024

Oral Vaccines Solutions for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Companion Animals Rabies Veterinary Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions